SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from Hoth Therapeutics, Inc. (HOTH) (CIK 0001711786) (RKTO) — Mar 9, 2020

Hoth Therapeutics, Inc. (HOTH) (CIK 0001711786)
Date: March 9, 2020 · CIK: 0001711786 · Accession: 0001213900-20-005745

Offering / Registration Process

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-236887

Date
March 9, 2020
Author
Robb Knie
Form
CORRESP
Company
Hoth Therapeutics, Inc. (HOTH) (CIK 0001711786)

Letter

Hoth Therapeutics, Inc.

1 Rockefeller Plaza, Suite 1039

New York, New York 10020

March 9, 2020

VIA EDGAR

United States Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Attention: Paul Fischer

Re: Hoth Therapeutics, Inc.

Registration Statement on Form S-3

File No. 333-236887

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Hoth Therapeutics, Inc. (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 4:30 p.m., Eastern Standard Time, on Wednesday March 11, 2020, or as soon thereafter as possible.

Please notify Richard Friedman of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (212) 634-3031 as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request.

HOTH THERAPEUTICS, INC.

By: /s/ Robb Knie

Name: Robb Knie

Title: Chief Executive Officer

Show Raw Text
CORRESP
1
filename1.htm

Hoth Therapeutics, Inc.

1 Rockefeller Plaza, Suite 1039

New York, New York 10020

    March 9, 2020

VIA
EDGAR

United
States Securities and Exchange Commission

100 F
Street, N.E.

Washington,
D.C. 20549

Attention:
Paul Fischer

Re:  Hoth
                                         Therapeutics, Inc.

    Registration
                                         Statement on Form S-3

    File
                                         No. 333-236887

Ladies and Gentlemen:

Pursuant to Rule 461
of the General Rules and Regulations under the Securities Act of 1933, as amended, Hoth Therapeutics, Inc. (the “Company”)
respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become
effective at 4:30 p.m., Eastern Standard Time, on Wednesday March 11, 2020, or as soon thereafter as possible.

Please notify Richard Friedman
of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (212) 634-3031 as soon as possible as to the time
the Registration Statement has been declared effective pursuant to this acceleration request.

    HOTH THERAPEUTICS, INC.

    By:
    /s/ Robb Knie

    Name:
     Robb Knie

    Title:
    Chief Executive Officer